SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Precision BioSciences Reports Positive Safety Review for PBGENE-DMD Trial

The first patient completed the post-treatment observation period with no reported safety issues, supporting additional dosing in the Phase 1/2 FUNCTION-DMD study.

DTIL

Related stories